Strome Mark E's Form 4 filing
Zivo Bioscience, Inc. (ZIVO) · filed Apr 24, 2026
- Accession no.
- 0001213900-26-047650
- Filed
- Apr 24, 2026, 6:16 PM ET
- Trade date
- Apr 17, 2026
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $200.0K. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Strome Mark ECIK 0000919484 | 10% Owner |
| Strome Investment Management LPCIK 0000936711 | Other: Affiliate of 10% Owner |
| Strome Group, Inc.CIK 0001724136 | Other: Affiliate of 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | Common Stock | PPurchaseAcquired | +100,000 | $2.00 | +$200,000 | 572,942 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.